{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:32:49Z","timestamp":1787668369054,"version":"build-2736575974"},"reference-count":33,"publisher":"The Society for Free Radical Research Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2021]]},"DOI":"10.3164\/jcbn.20-41","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T22:05:26Z","timestamp":1594850726000},"page":"101-104","source":"Crossref","is-referenced-by-count":18,"title":["The simplified Kyoto classification score is consistent with the ABC method of classification as a grading system for endoscopic gastritis"],"prefix":"10.3164","volume":"68","author":[{"given":"Toshihiro","family":"Nishizawa","sequence":"first","affiliation":[{"name":"Gastroenterology, Toyoshima Endoscopy Clinic"},{"name":"Department of Gastroenterology and Hepatology, International University of Health and Welfare, Mita Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Toyoshima","sequence":"additional","affiliation":[{"name":"Gastroenterology, Toyoshima Endoscopy Clinic"},{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kondo","sequence":"additional","affiliation":[{"name":"Gastroenterology, Toyoshima Endoscopy Clinic"},{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Sekiba","sequence":"additional","affiliation":[{"name":"Gastroenterology, Toyoshima Endoscopy Clinic"},{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Ebinuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, International University of Health and Welfare, Mita Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizu","family":"Tanikawa","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Sakitani K, Nishizawa T, Arita M, et al. Early detection of gastric cancer after <i>Helicobacter pylori<\/i> eradication due to endoscopic surveillance. Helicobacter 2018; 23: e12503.","DOI":"10.1111\/hel.12503"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Uemura N, Okamoto S, Yamamoto S, et al. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med 2001; 345: 784\u2013789.","DOI":"10.1056\/NEJMoa001999"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Nishizawa T, Suzuki H, Arano T, et al. Characteristics of gastric cancer detected within 1 year after successful eradication of <i>Helicobacter pylori<\/i>. J Clin Biochem Nutr 2016; 59: 226\u2013230.","DOI":"10.3164\/jcbn.16-43"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Hatakeyama M, Brzozowski T. Pathogenesis of <i>Helicobacter pylori<\/i> infection. Helicobacter 2006; 11 Suppl 1: 14\u201320.","DOI":"10.1111\/j.1478-405X.2006.00424.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Suzuki H, Nishizawa T, Tsugawa H, Mogami S, Hibi T. Roles of oxidative stress in stomach disorders. J Clin Biochem Nutr 2012; 50: 35\u201339.","DOI":"10.3164\/jcbn.11-115SR"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kodama M, Okimoto T, Mizukami K, et al. Differences in <i>Helicobacter pylori<\/i> and CagA antibody changes after eradication between subjects developing and not developing gastric cancer. J Clin Biochem Nutr 2019; 65: 71\u201375.","DOI":"10.3164\/jcbn.19-30"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Miki K. Gastric cancer screening by combined assay for serum anti-<i>Helicobacter pylori<\/i> IgG antibody and serum pepsinogen levels\u2014\u201cABC method\u201d. Proc Jpn Acad Ser B Phys Biol Sci 2011; 87: 405\u2013414.","DOI":"10.2183\/pjab.87.405"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kudo T, Kakizaki S, Sohara N, et al. Analysis of ABC (D) stratification for screening patients with gastric cancer. World J Gastroenterol 2011; 17: 4793\u20134798.","DOI":"10.3748\/wjg.v17.i43.4793"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Mizuno S, Miki I, Ishida T, et al. Prescreening of a high-risk group for gastric cancer by serologically determined <i>Helicobacter pylori<\/i> infection and atrophic gastritis. Dig Dis Sci 2010; 55: 3132\u20133237.","DOI":"10.1007\/s10620-010-1154-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Toyoshima O, Nishizawa T, Koike K. Endoscopic Kyoto classification of <i>Helicobacter pylori<\/i> infection and gastric cancer risk diagnosis. World J Gastroenterol 2020; 26: 466\u2013477.","DOI":"10.3748\/wjg.v26.i5.466"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Agawa S, Futagami S, Yamawaki H, et al. Acylated ghrelin levels were associated with depressive status, physical quality of life, endoscopic findings based on Kyoto classification in Japan. J Clin Biochem Nutr 2019; 65: 65\u201370.","DOI":"10.3164\/jcbn.18-111"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Koike K. Association between gastric cancer and the Kyoto classification of gastritis. J Gastroenterol Hepatol 2017; 32: 1581\u20131586.","DOI":"10.1111\/jgh.13764"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Sugimoto M, Ban H, Ichikawa H, et al. Efficacy of the Kyoto classification of gastritis in identifying patients at high risk for gastric cancer. Intern Med 2017; 56: 579\u2013586.","DOI":"10.2169\/internalmedicine.56.7775"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Nishizawa T, Suzuki H, Arita M, et al. Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy. J Clin Biochem Nutr 2018; 63: 230\u2013232.","DOI":"10.3164\/jcbn.18-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology 2007; 133: 675\u2013701.","DOI":"10.1053\/j.gastro.2007.06.002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Nishizawa T, Suzuki H, Sakitani K, et al. Family history is an independent risk factor for the progression of gastric atrophy among patients with <i>Helicobacter pylori<\/i> infection. United European Gastroenterol J 2017; 5: 32\u201336.","DOI":"10.1177\/2050640616642341"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 1: 87\u201397.","DOI":"10.1055\/s-0028-1098086"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Toyoshima O, Yamaji Y, Yoshida S, et al. Endoscopic gastric atrophy is strongly associated with gastric cancer development after <i>Helicobacter pylori<\/i> eradication. Surg Endosc 2017; 31: 2140\u20132148.","DOI":"10.1007\/s00464-016-5211-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Quach DT, Hiyama T. Assessment of endoscopic gastric atrophy according to the Kimura-Takemoto classification and its potential application in daily practice. Clin Endosc 2019; 52: 321\u2013327.","DOI":"10.5946\/ce.2019.072"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Fukuta N, Ida K, Kato T, et al.; Study Group for Investigating Endoscopic Diagnosis of Gastric Intestinal Metaplasia. Endoscopic diagnosis of gastric intestinal metaplasia: a prospective multicenter study. Dig Endosc 2013; 25: 526\u2013534.","DOI":"10.1111\/den.12032"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Toyoshima O, Nishizawa T, Sakitani K, et al. Serum anti-<i>Helicobacter pylori<\/i> antibody titer and its association with gastric nodularity, atrophy, and age: a cross-sectional study. World J Gastroenterol 2018; 24: 4061\u20134068.","DOI":"10.3748\/wjg.v24.i35.4061"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kishikawa H, Kimura K, Takarabe S, Kaida S, Nishida J. <i>Helicobacter pylori<\/i> antibody titer and gastric cancer screening. Dis Markers 2015; 2015: 156719.","DOI":"10.1155\/2015\/156719"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Nishizawa T, Suzuki H, Fujimoto A, et al. Effects of patient age and choice of antisecretory agent on success of eradication therapy for <i>Helicobacter pylori<\/i> infection. J Clin Biochem Nutr 2017; 60: 208\u2013210.","DOI":"10.3164\/jcbn.16-86"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Toyoshima O, Tanikawa C, Yamamoto R, et al. Decrease in <i>PSCA<\/i> expression caused by <i>Helicobacter pylori<\/i> infection may promote progression to severe gastritis. Oncotarget 2018; 9: 3936\u20133945.","DOI":"10.18632\/oncotarget.23278"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Watanabe M, Kato J, Inoue I, et al. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and <i>Helicobacter pylori<\/i> antibody together with endoscopic rugal hyperplastic gastritis. Int J Cancer 2012; 131: 2632\u20132642.","DOI":"10.1002\/ijc.27514"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Yoshida T, Kato J, Inoue I, et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and <i>Helicobacter pylori<\/i> antibody titer. Int J Cancer 2014; 134: 1445\u20131457.","DOI":"10.1002\/ijc.28470"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Yoon H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver 2015; 9: 5\u201317.","DOI":"10.5009\/gnl14118"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Chung SJ, Park MJ, Kang SJ, et al. Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea. Int J Cancer 2012; 131: 2376\u20132384.","DOI":"10.1002\/ijc.27501"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Nishibayashi H, Kanayama S, Kiyohara T, et al. <i>Helicobacter pylori<\/i>-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. J Gastroenterol Hepatol 2003; 18: 1384\u20131391.","DOI":"10.1046\/j.1440-1746.2003.03192.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Nishikawa I, Kato J, Terasoma S, et al. Nodular gastritis in association with gastric cancer development before and after <i>Helicobacter pylori<\/i> eradication. JGH Open 2018; 2: 80\u201386.","DOI":"10.1002\/jgh3.12049"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Suzuki M, Suzuki H, Minegishi Y, Ito K, Nishizawa T, Hibi T. <i>H. pylori<\/i>-eradication therapy increases RUNX3 expression in the glandular epithelial cells in enlarged-fold gastritis. J Clin Biochem Nutr 2010; 46: 259\u2013264.","DOI":"10.3164\/jcbn.09-127"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with <i>Helicobacter pylori<\/i> infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138\u2013143.","DOI":"10.1002\/ijc.11680"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Sakitani K, Hirata Y, Watabe H, et al. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J Gastroenterol Hepatol 2011; 26: 1570\u20131575.","DOI":"10.1111\/j.1440-1746.2011.06767.x"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/68\/1\/68_20-41\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T03:51:24Z","timestamp":1609559484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/68\/1\/68_20-41\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.20-41","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}